1-6 of 6
Ming Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy

Free
Qinghai Zeng, Jianye Liu, Peiguo Cao, Jingjing Li, Xiaoming Liu, Xiaojun Fan, Ling Liu, Yan Cheng, Wei Xiong, Jigang Li, Hao Bo, Yuxing Zhu, Fei Yang, Jun Hu, Ming Zhou, Yanhong Zhou, Qiong Zou, Jianda Zhou, Ke Cao
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2): 445–459.
https://doi.org/10.1158/1078-0432.CCR-17-0419
Published: 15 January 2018
View articletitled, Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy
Open the PDF for Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy in another window
Includes: Supplementary data
Journal Articles

mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo

Free
James J. Morrow, Arnulfo Mendoza, Allyson Koyen, Michael M. Lizardo, Ling Ren, Timothy J. Waybright, Ryan J. Hansen, Daniel L. Gustafson, Ming Zhou, Timothy M. Fan, Peter C. Scacheri, Chand Khanna
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (24): 6129–6141.
https://doi.org/10.1158/1078-0432.CCR-16-0326
Published: 15 December 2016
View articletitled, mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo
Open the PDF for mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo in another window
Includes: Supplementary data
Journal Articles

Abstract B50: A new class of diazonamide analogs with improved antitumor activity

Free
Lin Li, Qi Wei, Ming Zhou, Vijayashree Ramesh, Xiaodong Wang, Patrick G. Harran, Lai Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): B50.
https://doi.org/10.1158/1078-0432.TCMUSA10-B50
Published: 02 February 2016
View articletitled, Abstract B50: A new class of diazonamide analogs with improved antitumor activity
Journal Articles

Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma

Free
Rongrong Wei, Guo-Liang Huang, Mei-Yin Zhang, Bin-Kui Li, Hui-Zhong Zhang, Ming Shi, Xiao-Qian Chen, Long Huang, Qing-Ming Zhou, Wei-Hua Jia, X.F. Steven Zheng, Yun-Fei Yuan, Hui-Yun Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (17): 4780–4791.
https://doi.org/10.1158/1078-0432.CCR-12-2728
Published: 02 September 2013
View articletitled, Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma
Open the PDF for Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma

Free
Liang Cheng, Gregory T. MacLennan, Shaobo Zhang, Mingsheng Wang, Ming Zhou, Puay-Hoon Tan, Stephanie Foster, Antonio Lopez-Beltran, Rodolfo Montironi
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (24): 8087–8093.
https://doi.org/10.1158/1078-0432.CCR-08-1494
Published: 15 December 2008
View articletitled, Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma
Open the PDF for Evidence for Polyclonal Origin of Multifocal Clear Cell Renal Cell Carcinoma in another window
Journal Articles

Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma

Free
Christopher J. Herrem, Tomohide Tatsumi, Kathleen S. Olson, Keisuke Shirai, James H. Finke, Ronald M. Bukowski, Ming Zhou, Amy L. Richmond, Ithaar Derweesh, Michael S. Kinch, Walter J. Storkus
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 226–231.
https://doi.org/10.1158/1078-0432.226.11.1
Published: 21 January 2005
View articletitled, Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma
Open the PDF for Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma in another window